Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

biOasis Technologies Ord Shs BIOAF


Primary Symbol: V.BTI.H

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by prophetoffactzon Mar 01, 2023 8:27am
293 Views
Post# 35311864

22 days since...

22 days since...

22 days since narmac posted:

"Hummmm,,well,,,,where did this informatuion come from,,,,,,,you say Bioasis is dead??,,no,,you arent rerading the info,,,the deal is dead,,,,not Bioasis,,,,,,good grief,,,far from the truth imo,,,,cuz,,thats not what I am hearing,,,,all the contacts I have chatted with point to serious activity behind the scenes as I type......there is more than one group which finance public companies...&...there are numerous other business models to follow,,,,,"

Cash until March and we are here...
20 days ago Midatech announced its financing with Ladenberg.
BTI was recognized as far more valuable in the Biodexa transaction.
If all that was next for BTI was a financing it should have been announced some time ago.
Something more complicated?

Are the lights even on? Today BTI Tweets that it is committed to developing treatments for rare brain diseases on #RareDiseaseDay. The lights still appear to be on with a commitment.

What happens next?

 

<< Previous
Bullboard Posts
Next >>